Kevin D. Houston

ORCID: 0000-0002-9858-1901

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation”.

IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation

Frontiers in Endocrinology(2020)10.3389/fendo.2020.00233

N/A

0DataRank · unranked

31 citations

Janel Y. Sowers, Kevin D. Houston, Zheng Yan

Investigating differences between tamoxifen resistant and sensitive breast cancer cells with flow cytometry

Cytometry Part A(2021)10.1002/cyto.a.24306

N/A

0DataRank · unranked

4 citations

Zheng Yan, Jessica P. Houston, Kevin D. Houston, Aric Bitton

Correlating NAD(P)H lifetime shifts to tamoxifen resistance in breast cancer cells: A metabolic screening study with time-resolved flow cytometry

Journal of Innovative Optical Health Sciences(2024)10.1142/s1793545824500202

N/A

0DataRank · unranked

4 citations

Karla Ortega-Sandoval, Kevin D. Houston, Jessica P. Houston, Samantha Valentino

IGFBP-6 regulates breast cancer cell cycle progression by promoting exit out of G1

Journal of Biological Chemistry(2025)10.1016/j.jbc.2025.111069

N/A

0DataRank · unranked

1 citations

Shayla Hernandez, Diana C. Bautista-Tovar, Kevin D. Houston, Francisco Javier Lariz